XML 49 R36.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Information (Tables)
 9 Months Ended 12 Months Ended
May 31, 2025
Aug. 31, 2024
Segment Information    
Schedule of profit or loss and total assets for each reportable segment

Nine months Ended May 31, 2025

 

IP

Licensing

 

 

B2B

Product

 

 

R&D

 

 

Corporate

 

 

Consolidated

Total

 

Revenue

 

$522,000

 

 

$9,923

 

 

$-

 

 

$-

 

 

$531,923

 

Cost of goods sold

 

 

-

 

 

 

(2,720 )

 

 

-

 

 

 

-

 

 

 

(2,720 )

Operating expenses

 

 

(10,924 )

 

 

(10,116 )

 

 

(6,356,636 )

 

 

(3,343,667 )

 

 

(9,721,343 )

Other Income (Expense)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(22,066)

 

 

(22,066)

Segment Income (Loss)

 

$511,076

 

 

$(2,913)

 

$(6,356,636 )

 

$(3,365,733 )

 

$(9,214,206 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

$165,649

 

 

$56,656

 

 

$513,646

 

 

$6,005,415

 

 

$6,741,366

 

Nine Months Ended May 31, 2024

 

IP

Licensing

 

 

B2B

Product

 

 

R&D

 

 

Corporate

 

 

Consolidated

Total

 

Revenue

 

$373,990

 

 

$5,388

 

 

$900

 

 

$-

 

 

$380,278

 

Cost of goods sold

 

 

-

 

 

 

(4,822 )

 

 

-

 

 

 

-

 

 

 

(4,822 )

Operating expenses

 

 

(130 )

 

 

(288 )

 

 

(1,393,359 )

 

 

(2,531,745 )

 

 

(3,925,522 )

Other Income (Expense)

 

 

 -

 

 

 

-

 

 

 

-

 

 

 

(72,017 )

 

 

(72,017 )

Segment Income (Loss)

 

$373,860

 

 

$278

 

 

$(1,392,459 )

 

$(2,603,762 )

 

$(3,622,083 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

$124,968

 

 

$63,573

 

 

$475,194

 

 

$9,354,702

 

 

$10,018,437

 

 

 

IP

 

 

B2B

 

 

 

 

 

 

 

 

Consolidated

 

Year Ended August 31, 2024

 

Licensing

 

 

Product

 

 

R&D

 

 

Corporate

 

 

Total

 

Revenue

 

$457,990

 

 

$5,388

 

 

$900

 

 

$-

 

 

$464,278

 

Cost of goods sold

 

 

 

 

 

 

(4,822)

 

 

 

 

 

 

 

 

 

 

(4,822)

Operating expenses

 

 

(340)

 

 

(1,124)

 

 

(2,360,565)

 

 

(3,850,557)

 

 

(6,212,586)

Other income/(expense)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(55,524)

 

 

(55,524)

Segment loss

 

$457,650

 

 

$(558)

 

$(2,359,665)

 

$(3,906,081)

 

$(5,808,654)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

$164,152

 

 

$63,131

 

 

$497,603

 

 

$8,142,903

 

 

$8,867,789

 

 

 

 

IP

 

 

B2B

 

 

 

 

 

 

 

 

Consolidated

 

Year Ended August 31, 2023

 

Licensing

 

 

Product

 

 

 R&D 

 

 

 Corporate

 

 

 Total

 

Revenue

 

$146,800

 

 

$44,167

 

 

$35,241

 

 

$-

 

 

$226,208

 

Cost of goods sold

 

 

-

 

 

 

(31,500)

 

 

-

 

 

 

-

 

 

$(31,500)

Operating expenses

 

 

(70,677)

 

 

(282,709)

 

 

(3,666,721)

 

 

(2,708,623)

 

$(6,728,730)

Other income/(expense)

 

 

 

 

 

 

-

 

 

 

-

 

 

 

(178,503)

 

$(178,503)

Segment loss

 

$76,123

 

 

$(270,042)

 

$(3,631,480)

 

$(2,887,126)

 

$(6,712,525)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Total assets

 

$103,336

 

 

$65,573

 

 

$187,532

 

 

$2,729,545

 

 

$3,083,986